123 related articles for article (PubMed ID: 3472643)
21. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
[TBL] [Abstract][Full Text] [Related]
22. Rearrangements of chromosomal regions containing ribosomal RNA genes and centromeric heterochromatin in the human melanoma cell line MeWo.
Holden JJ; Reimer DL; Roder JC; White BN
Cancer Genet Cytogenet; 1986 Apr; 21(3):221-37. PubMed ID: 3456262
[TBL] [Abstract][Full Text] [Related]
23. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
[TBL] [Abstract][Full Text] [Related]
24. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
[TBL] [Abstract][Full Text] [Related]
25. Multiple karyotypic abnormalities, including structural rearrangements of 11p, in cell lines from malignant melanomas.
Heim S; Mandahl N; Arheden K; Giovanella BC; Yim SO; Stehlin JS; Mitelman F
Cancer Genet Cytogenet; 1988 Oct; 35(1):5-20. PubMed ID: 3180009
[TBL] [Abstract][Full Text] [Related]
26. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
[TBL] [Abstract][Full Text] [Related]
27. Karyotypic analysis of murine cytolytic T-cell lines.
Cianfriglia M; Johnson JP; Nabholz M
Cancer Genet Cytogenet; 1984 Apr; 11(4):369-79. PubMed ID: 6608401
[TBL] [Abstract][Full Text] [Related]
28. Plasma cell karyotype in multiple myeloma.
Gould J; Alexanian R; Goodacre A; Pathak S; Hecht B; Barlogie B
Blood; 1988 Feb; 71(2):453-6. PubMed ID: 3337907
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic studies of esophageal carcinoma cell lines.
Whang-Peng J; Banks-Schlegel SP; Lee EC
Cancer Genet Cytogenet; 1990 Mar; 45(1):101-20. PubMed ID: 2302677
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene.
Gazdar AF; Oie HK; Kirsch IR; Hollis GF
Blood; 1986 Jun; 67(6):1542-9. PubMed ID: 2423157
[TBL] [Abstract][Full Text] [Related]
31. Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses.
Sáez B; Martín-Subero JI; Largo C; Martín MC; Odero MD; Prosper F; Siebert R; Calasanz MJ; Cigudosa JC
Cancer Genet Cytogenet; 2006 Sep; 169(2):143-9. PubMed ID: 16938572
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetics of multiple myeloma.
Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
[TBL] [Abstract][Full Text] [Related]
33. Establishment and characterization of a cytogenetically complex Chinese multiple myeloma-derived cell line with homozygous p53 deletion and cyclin E overexpression.
Cheng SH; Ng MH; Tsang KS; Lau KM; Chan JC; Liu HS; Chu RW; Poon CS; Ng HK
Int J Oncol; 2004 May; 24(5):1141-8. PubMed ID: 15067335
[TBL] [Abstract][Full Text] [Related]
34. [Cytogenetic study of multiple myeloma].
Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regions in myeloma cell lines.
Kuipers J; Vaandrager JW; Weghuis DO; Pearson PL; Scheres J; Lokhorst HM; Clevers H; Bast BJ
Cancer Genet Cytogenet; 1999 Mar; 109(2):99-107. PubMed ID: 10087940
[TBL] [Abstract][Full Text] [Related]
36. [Karyotypic variability of human myeloma cell lines].
Turilova VK; Smirnova TD
Tsitologiia; 2012; 54(8):621-36. PubMed ID: 23074853
[TBL] [Abstract][Full Text] [Related]
37. [Karyotypic characteristics of the murine myeloma line sp2/0-Ag14].
Sorokina EA; Kozhukharova IV; Grinchuk TM
Tsitologiia; 1986 Jun; 28(6):623-8. PubMed ID: 3463006
[TBL] [Abstract][Full Text] [Related]
38. Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996).
Jernberg H; Nilsson K; Zech L; Lutz D; Nowotny H; Scheirer W
Blood; 1987 Jun; 69(6):1605-12. PubMed ID: 3580570
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.
Rajkumar SV; Fonseca R; Dewald GW; Therneau TM; Lacy MQ; Kyle RA; Greipp PR; Gertz MA
Cancer Genet Cytogenet; 1999 Aug; 113(1):73-7. PubMed ID: 10459351
[TBL] [Abstract][Full Text] [Related]
40. The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma.
González MB; Hernández JM; García JL; Lumbreras E; Castellanos M; Hernández JM; Fernández-Calvo J; Gutiérrez NC; San Miguel JF
Haematologica; 2004 Oct; 89(10):1213-8. PubMed ID: 15477206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]